Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Experimental and Molecular Pathology|October 1, 1985
X-ray microanalysis of mineralized matrix vesicles of experimental saccular aneurysmsN S Greenhill, M R Presland, K M Rogers, et al.
British Journal of Anaesthesia|August 1, 1980
Preliminary experience with ICI 35 868 as an i.v. induction agent: comparison with althesinK M Rogers, K M Dewar, T D McCubbin, et al.
Scottish Medical Journal|July 1, 1984
Treatment of intractable neurogenic pain with carbamazepineW G Rapeport, K M Rogers, T D McCubbin, et al.
European Journal of Cancer Care|February 3, 2017
Reduced prevalence of pain and distress during 4 years of screening with QUICATOUCH in Australian oncology patientsK A Clover, K M Rogers, B Britton, et al.
Anaesthesia|July 1, 1996
Audit in pain clinics: changing the management of low-back and nerve-damage painH T Davies, I K Crombie, W A Macrae, et al.
Equine Veterinary Journal. Supplement|November 28, 2001
The effect of shoe material on the kinetics and kinematics of foot slip at impact on concreteC H Pardoe, M P McGuigan, K M Rogers, et al.
The Australian and New Zealand Journal of Surgery|October 1, 1989
Factors affecting MSA levels in normal women and women with breast cancerY C Smart, K M Rogers, J H Brien, et al.
The Journal of Endocrinology|February 1, 1995
Induction of an acute phase response in lambs causes an increase in plasma levels of GH and IGF-IL G Moore, A Pfeffer, W N Chie, et al.
Virology|February 14, 2009
Type I IFN response to Papiine herpesvirus 2 (Herpesvirus papio 2; HVP2) determines neuropathogenicity in miceK M Rogers, M Deatheridge, M A Breshears, et al.
The Journal of Biological Chemistry|March 10, 1981
The 20,000 molecular weight variant of human growth hormone. Preparation and some physical and chemical propertiesG E Chapman, K M Rogers, T Brittain, et al.
Pageof 3